SEARCH:
Print

Board of Directors

The Board of Directors of Bavarian Nordic consists of six external members elected by the shareholders at the annual general meeting for terms of one year, and four members elected by the employees for terms of four years.

The Board discharges its duties in accordance with the rules of procedure of the Board, which are reviewed and updated by all members of the Board.

To support the Board in its duties, the Board has established and appointed three subcommittees that are charged with reviewing issues pertaining to their respective fields that are due to be considered at board meetings. An overview the commitees and written charters specifying the tasks and responsibilities for each of the committees are available here.


Gerard van Odijk, MD

Gerard van Odijk, MD

Member of the board since 2008 and chairman since 2014. Not independent. Current term expires in 2023. Chairman of the Nomination and Compensation Committee since 2015 and member of the Science Technology & Investment Committee since 2020.

Dr. van Odijk is a Dutch national, born in 1957.

Former president and chief executive officer of Teva Pharmaceuticals Europe B.V.

Current positions: Chairman of the supervisory board of Hubrecht Organoid Technology. Member of the supervisory board of Centre for Human Drug Research.

Special competences: Medical qualifications and extensive executive background within publicly traded and private companies in the international healthcare industry.

Anders Gersel Pedersen, MD, PhD

Anders Gersel Pedersen, MD, PhD

Member of the board since 2010 and deputy chairman since 2014. Not independent. Current term expires in 2023. Member of the Science Technology & Investment Committee since 2020 and member of the Finance, RIsk and Audit Committee since 2022.

Dr. Pedersen is a Danish national, born in 1951.

Former Executive Vice President of Research & Development of H. Lundbeck A/S.

Current positions: Member of the board of Genmab A/S, Hansa Biopharma AB and Bond Avillion 2, an entity of Avillion LLP. Chairman of the board of Aelis Farma. Dr. Pedersen is also the CEO in his private holding company Gerselconsult ApS. 

Special competences: Scientific knowledge and large drug development experience within neuroscience and oncology. Extensive board and management experience from publicly traded, international pharmaceutical and biotech companies.

Peter Kürstein, MBA

Peter Kürstein, MBA

Member of the board since 2012. Independent. Current term expires in 2023. Member of the Nomination and Compensation Committee since 2015 and member of the Finance, Risk and Audit Committee since 2020.

Mr. Kürstein is a Danish national, born in 1956.

Former president and chief executive officer of Radiometer Medical ApS.

Current positions: Chairman of the board of Ferrosan Medical Devices Holding A/S. Deputy Chairman of the board of FOSS A/S, Experimentarium and American Chamber of Commerce. Member of the board of N. Foss & Co. A/S and Den Erhvervsdrivende Fond Gl. Strand, Dansk BørneAstma Center and Art Agenda 2030. Member of the executive board of Mijamax ApS.

Special competences: Extensive board and management experience from publicly traded, international healthcare companies.

Frank Verwiel, MD

Frank Verwiel, MD

Member of the board since 2016. Independent. Current term expires in 2023. Member of the Nomination and Compensation Committee since 2020 and member of the Science, Technology and Investment Committee since 2022.

Dr. Verwiel is a Dutch national, now resident of the USA, born in 1962.

Former president and chief executive officer of Aptalis Pharma, Inc.

Current positions: Chair of the board of ObsEva SA and Intellia Therapeutics, Inc.

Special competences: Extensive strategic, operational and international experience within the pharmaceutical industry.

Elizabeth McKee Anderson, MBA

Elizabeth McKee Anderson, MBA

Member of the board since 2017. Independent. Current term expires in 2023. Chairman of the Science Technology & Investment Committee since 2020 and member of the Nomination and Compensation Committee since 2022.

Ms. Anderson is an American national, born in 1957.

Former worldwide vice president, Global Strategic Marketing and Market Access, Infectious Diseases and Vaccines for Johnson&Johnson. Former member of Huntsworth plc, and Context Therapeutics LLC. 

Current positions: Member of the board of Revolution Medicines Inc., BioMarin Pharmaceutical Inc., Insmed Inc., Aro Biotherapeutics Company and a member of the advisory Board of NAXION, Inc. Trustee of The Wistar Institute and principal of PureSight Advisory, LLC. 

Special competences: Extensive strategic, operational and international experience within the pharmaceutical industry.

Anne Louise Eberhard, MSc Law

Anne Louise Eberhard, MSc Law

Member of the board since 2019. Independent. Current term expires in 2023. Chairman of the Finance, Risk and Audit Committee since 2020 and member of the Science, Technology and Investment Committee since 2022.

Ms. Eberhard is a Danish national, born in 1963.

Former Senior Executive Vice President and Global Head of Corporate & Institutional Banking at Danske Bank A/S, and Chief Commercial Officer at Intrum AB.

Current positions: Chair of the board of Moneyflow Group A/S and its subsidiary Moneyflow 1 A/S. Deputy Chair of the board of Finansiel Stabilitet SOV. Member of the board of FLSmidth & Co. A/S and its subsidiary FLSmidth A/S, Knud Højgaards Fond and two of its three subsidiarie, VL 52 ApS and Den Danske Unicef Fond. CEO of EA Advice ApS. Faculty Member at Copenhagen Business School, Board Educations.

Special competences: Extensive finance, risk management and ESG experience as well as board experience from publicly listed companies.

Linette Munksgaard Andersen

Linette Munksgaard Andersen

Employee-elected member of the board since 2021. Current term expires in 2025.

Ms. Munksgaard is a Danish national, born in 1974.

Manager, Customer Service, Shipping & Distribution

Thomas Alex Bennekov

Thomas Alex Bennekov

Employee-elected member of the board since 2021. Current term expires in 2025.

Mr. Bennekov is a Danish national, born in 1968.

Sr. App. & Integration Analyst.

Anja Gjøl

Anja Gjøl

Employee-elected member of the board since 2021. Current term expires in 2025.

Ms. Gjøl is a Danish national, born in 1980.

Scientist.

Karen Merete Jensen

Karen Merete Jensen

Employee-elected member of the board since 2021. Current term expires in 2025.

Ms. Jensen is a Danish national, born in 1959.

QA Specialist.